Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-22

FDA Approved: MESALAMINE — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved mesalamine under an Original Application (ANDA) for Teva Pharmaceuticals, enabling marketing of a generic mesalamine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)